Herman Skolnik Award Symposium 2015 Honoring Jürgen Bajorath

Introduction Veerabahu (Veer) Shanmugasundaram of Pfizer, who chaired the symposium, gave a brief introduction highlighting Jürgen’s achievements. (A lengthier tribute has appeared at http://bulletin.acscinf.org/node/655.) Jürgen obtained his diploma (M.S.) and Ph.D. degrees (under Wolfram Saenger) in biochemistry from the Free University of Berlin. He then did postdoctoral studies with Arnie Hagler at Biosym in San Diego, focusing on DFT calculations of enzyme-inhibitor complexes. At Bristol-Myers Squibb he worked on protein modeling and structure-based design projects and developed his interests in bioinformatics and cheminformatics research. During his tenure at New Chemical Entities, he firmly established himself as a thought leader in cheminformatics. After 16 years in the United States, he returned to Germany where he is currently Professor and Chair of Life Sciences Informatics at the University of Bonn. Jürgen is a leader in the development and application of cheminformatics and computational solutions to research problems in medicinal chemistry, chemical biology and life sciences. He has done pioneering work in compound-centric data visualization and analysis in chemistry and is widely recognized for his seminal and prolific research work in several areas that are of interest to industry. His research interests include large-scale graphical SAR analysis, navigating high-dimensional space, multi-target modeling, machine learning and virtual screening.

[1]  P. J. Harrison,et al.  A Method of Cluster Analysis and Some Applications , 1968 .

[2]  W. Tobler.  A Computer Movie Simulating Urban Growth in the Detroit Region , 1970 .

[3]  George W. Adamson,et al.  A Comparison of the Performance of Some Similarity and Dissimilarity Measures in the Automatic Classification of Chemical Structures , 1975, J. Chem. Inf. Comput. Sci..

[4]  M. Randic,et al.  A GRAPH THEORETICAL APPROACH TO STRUCTURE‐PROPERTY AND STRUCTURE‐ACTIVITY CORRELATIONS , 1981 .

[5]  R. Venkataraghavan,et al.  Atom pairs as molecular features in structure-activity studies: definition and applications , 1985, J. Chem. Inf. Comput. Sci..

[6]  Peter Willett,et al.  Implementation of nonhierarchic cluster analysis methods in chemical information systems: selection of compounds for biological testing and clustering of substructure search output , 1986, J. Chem. Inf. Comput. Sci..

[7]  Marvin Johnson,et al.  Concepts and applications of molecular similarity , 1990 .

[8]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[9]  P. Linsley,et al.  Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.

[10]  D C Spellmeyer,et al.  Measuring diversity: experimental design of combinatorial libraries for drug discovery. , 1995, Journal of medicinal chemistry.

[11]  Robert D Clark,et al.  Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.

[12]  Robert P. Sheridan,et al.  Chemical Similarity Using Physiochemical Property Descriptors , 1996, J. Chem. Inf. Comput. Sci..

[13]  P Willett,et al.  Comparison of algorithms for dissimilarity-based compound selection. , 1997, Journal of molecular graphics & modelling.

[14]  A. Hopfinger,et al.  Construction of 3D-QSAR Models Using the 4D-QSAR Analysis Formalism , 1997 .

[15]  Christopher M. Bishop,et al.  GTM: The Generative Topographic Mapping , 1998, Neural Computation.

[16]  P. Willett,et al.  Combination of molecular similarity measures using data fusion , 2000 .

[17]  G. Zhu,et al.  B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. , 2003, Immunity.

[18]  A. Hopfinger,et al.  Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis. , 2004, Journal of medicinal chemistry.

[19]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[20]  Gisbert Schneider,et al.  Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.

[21]  Alexandre Varnek,et al.  Substructural fragments: an universal language to encode reactions, molecular and supramolecular structures , 2005, J. Comput. Aided Mol. Des..

[22]  Gisbert Schneider,et al.  Kernel Approach to Molecular Similarity Based on Iterative Graph Similarity , 2007, J. Chem. Inf. Model..

[23]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[24]  Robert P Sheridan,et al.  Chemical similarity searches: when is complexity justified? , 2007, Expert opinion on drug discovery.

[25]  Dimitris K Agrafiotis,et al.  SAR maps: a new SAR visualization technique for medicinal chemists. , 2007, Journal of medicinal chemistry.

[26]  Alexandre Varnek,et al.  Stochastic versus Stepwise Strategies for Quantitative Structure-Activity Relationship GenerationHow Much Effort May the Mining for Successful QSAR Models Take? , 2007, J. Chem. Inf. Model..

[27]  I. Tetko,et al.  ISIDA - Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors , 2008 .

[28]  R. Solé,et al.  Data completeness—the Achilles heel of drug-target networks , 2008, Nature Biotechnology.

[29]  Wolfgang Guba,et al.  Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity. , 2008, Journal of medicinal chemistry.

[30]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[31]  Gisbert Schneider,et al.  Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.

[32]  Jürgen Bajorath,et al.  Exploration of structure-activity relationship determinants in analogue series. , 2009, Journal of medicinal chemistry.

[33]  Jürgen Bajorath,et al.  From Structure–Activity to Structure–Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds , 2009, ChemMedChem.

[34]  A. Hopfinger,et al.  The receptor-dependent QSAR paradigm: an overview of the current state of the art. , 2009, Medicinal chemistry (Shariqah (United Arab Emirates)).

[35]  Gisbert Schneider,et al.  Graph Kernels for Molecular Similarity , 2010, Molecular informatics.

[36]  Eugen Lounkine,et al.  Activity-Aware Clustering of High Throughput Screening Data and Elucidation of Orthogonal Structure-Activity Relationships , 2011, J. Chem. Inf. Model..

[37]  H. K. Kim,et al.  Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib , 2011, Blood cancer journal.

[38]  Philip E. Bourne,et al.  PROMISCUOUS: a database for network-based drug-repositioning , 2010, Nucleic Acids Res..

[39]  Jürgen Bajorath,et al.  Molecular Mechanism-Based Network-like Similarity Graphs Reveal Relationships between Different Types of Receptor Ligands and Structural Changes that Determine Agonistic, Inverse-Agonistic, and Antagonistic Effects , 2011, J. Chem. Inf. Model..

[40]  Markus Hartenfeller,et al.  De novo drug design. , 2010, Methods in molecular biology.

[41]  Jürgen Bajorath,et al.  SAR Monitoring of Evolving Compound Data Sets Using Activity Landscapes , 2011, J. Chem. Inf. Model..

[42]  Héléna A. Gaspar,et al.  Generative Topographic Mapping (GTM): Universal Tool for Data Visualization, Structure‐Activity Modeling and Dataset Comparison , 2012, Molecular informatics.

[43]  Peter S. Kutchukian,et al.  Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.

[44]  Anne Mai Wassermann,et al.  SAR Matrices: Automated Extraction of Information-Rich SAR Tables from Large Compound Data Sets , 2012, J. Chem. Inf. Model..

[45]  Jonas Boström,et al.  Exploiting Structural Information in Patent Specifications for Key Compound Prediction , 2012, J. Chem. Inf. Model..

[46]  Markus Hartenfeller,et al.  DOGS: Reaction-Driven de novo Design of Bioactive Compounds , 2012, PLoS Comput. Biol..

[47]  Jürgen Bajorath,et al.  Activity profile relationships between structurally similar promiscuous compounds. , 2013, European journal of medicinal chemistry.

[48]  Anne Mai Wassermann,et al.  Biodiversity of small molecules--a new perspective in screening set selection. , 2013, Drug discovery today.

[49]  Petra Schneider,et al.  Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for ‘Orphan’ Molecules , 2013, Molecular informatics.

[50]  Alban Arrault,et al.  Generative Topographic Mapping-Based Classification Models and Their Applicability Domain: Application to the Biopharmaceutics Drug Disposition Classification System (BDDCS) , 2013, J. Chem. Inf. Model..

[51]  Helge G. Roider,et al.  Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network , 2013, BMC Bioinformatics.

[52]  Jürgen Bajorath,et al.  Promiscuity profiles of bioactive compounds: potency range and difference distributions and the relation to target numbers and families , 2013 .

[53]  Markus Hartenfeller,et al.  Drugs by numbers: reaction-driven de novo design of potent and selective anticancer leads. , 2013, Angewandte Chemie.

[54]  Anne Mai Wassermann,et al.  Bioturbo Similarity Searching: Combining Chemical and Biological Similarity To Discover Structurally Diverse Bioactive Molecules , 2013, J. Chem. Inf. Model..

[55]  Petra Schneider,et al.  Revealing the macromolecular targets of complex natural products. , 2014, Nature chemistry.

[56]  Gilles Marcou,et al.  Simple Ligand–Receptor Interaction Descriptor (SILIRID) for alignment-free binding site comparison , 2014, Computational and structural biotechnology journal.

[57]  Petra Schneider,et al.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus , 2014, Proceedings of the National Academy of Sciences.

[58]  K. Funatsu,et al.  Multivariate Statistical Process Control Method Including Soft Sensors for Both Early and Accurate Fault Detection , 2014 .

[59]  Petra Schneider,et al.  Multi-objective molecular de novo design by adaptive fragment prioritization. , 2014, Angewandte Chemie.

[60]  Petra Schneider,et al.  Accessing new chemical entities through microfluidic systems. , 2014, Angewandte Chemie.

[61]  S. Haggarty,et al.  Automated Structure–Activity Relationship Mining , 2014, Journal of biomolecular screening.

[62]  Ross McGuire,et al.  Data-driven medicinal chemistry in the era of big data. , 2014, Drug discovery today.

[63]  Jürgen Bajorath,et al.  Influence of Search Parameters and Criteria on Compound Selection, Promiscuity, and Pan Assay Interference Characteristics , 2014, J. Chem. Inf. Model..

[64]  Hiromasa Kaneko,et al.  Database monitoring index for adaptive soft sensors and the application to industrial process , 2014 .

[65]  Jürgen Bajorath,et al.  AnalogExplorer: a new method for graphical analysis of analog series and associated structure-activity relationship information. , 2014, Journal of medicinal chemistry.

[66]  G. Schneider,et al.  Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands. , 2014, Angewandte Chemie.

[67]  Yanli Wang,et al.  PubChem BioAssay: 2014 update , 2013, Nucleic Acids Res..

[68]  Jürgen Bajorath,et al.  Neighborhood-Based Prediction of Novel Active Compounds from SAR Matrices , 2014, J. Chem. Inf. Model..

[69]  Jürgen Bajorath,et al.  Quantifying the Tendency of Therapeutic Target Proteins to Bind Promiscuous or Selective Compounds , 2015, PloS one.

[70]  J. Bajorath,et al.  Promiscuity progression of bioactive compounds over time , 2015, F1000Research.

[71]  Dragos Horvath,et al.  Chemical Data Visualization and Analysis with Incremental Generative Topographic Mapping: Big Data Challenge , 2015, J. Chem. Inf. Model..

[72]  Héléna A. Gaspar,et al.  GTM‐Based QSAR Models and Their Applicability Domains , 2015, Molecular informatics.

[73]  G. Schneider,et al.  Revealing the Macromolecular Targets of Fragment-Like Natural Products. , 2015, Angewandte Chemie.

[74]  Gisbert Schneider,et al.  Multidimensional de novo design reveals 5-HT2B receptor-selective ligands. , 2015, Angewandte Chemie.

[75]  Richard D. Cramer,et al.  Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities , 2015, PloS one.